HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clint D Kingsley Selected Research

KRN-330

8/2014Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Clint D Kingsley Research Topics

Disease

1Neutropenia
08/2014
1Colorectal Neoplasms (Colorectal Cancer)
08/2014
1Disease Progression
08/2014

Drug/Important Bio-Agent (IBA)

1KRN-330IBA
08/2014
1Irinotecan (Camptosar)FDA LinkGeneric
08/2014
1Monoclonal AntibodiesIBA
08/2014
1Differentiation AntigensIBA
08/2014